| Recruiting | Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN C3 Glomerulopathy, Idiopathic Immune Complex-Mediated Glomerulonephritis | Phase 2 | 2024-03-01 |
| Recruiting | Long-Term Safety, Tolerability and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | 2024-02-19 |
| Recruiting | Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transpla Thrombotic Microangiopathies, Hematopoietic Stem Cell Transplantation | Phase 2 | 2023-05-01 |
| Completed | Safety and Efficacy of OMS906 in Paroxysmal Nocturnal Hemoglobinuria Patients With a Sub-optimal Response to R Paroxysmal Nocturnal Hemoglobinuria | Phase 2 | 2023-03-27 |
| Unknown | Study of the Safety and Efficacy of OMS906 in Patients With Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria | Phase 1 | 2022-12-09 |
| Terminated | Safety and Efficacy Study of OMS721 in Patients With Atypical Hemolytic Uremic Syndrome Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome | Phase 3 | 2018-05-02 |
| Terminated | Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy IgA Nephropathy | Phase 3 | 2018-04-05 |
| Terminated | Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721 IgAN, LN, MN | Phase 2 | 2016-03-10 |
| Completed | Safety and Efficacy Study of OMS721 in Patients With Thrombotic Microangiopathies Thrombotic Microangiopathies | Phase 2 | 2014-11-02 |
| Completed | A Randomized Study in Children Ages Birth Through Three Years Undergoing Unilateral Cataract Extraction With o Unilateral Cataract Extraction, Congenital Cataract | Phase 3 | 2014-07-01 |
| Terminated | Intraoperative Floppy Iris Syndrome Undergoing Intraocular Lens Replacement Surgery Intraocular Lens Replacement, Intraoperative Floppy Iris Syndrome | Phase 3 | 2014-02-01 |
| Terminated | Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease Huntington's Disease | Phase 2 | 2014-01-01 |
| Completed | Safety, Tolerability, and Pharmacokinetics of OMS643762 in Psychiatrically Stable Schizophrenia Subjects Schizophrenia | Phase 2 | 2013-09-01 |
| Completed | Safety, Efficacy and Pharmacokinetics of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phaco Intraocular Lens Replacement | Phase 3 | 2012-04-01 |
| Completed | Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification Intraocular Lens Replacement | Phase 3 | 2011-09-01 |
| Completed | Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopi Meniscal Tear | Phase 3 | 2011-08-01 |
| Completed | Safety and Efficacy of OMS302 in Subjects Undergoing Unilateral Cataract Extraction With Lens Replacement (CEL Cataract | Phase 2 | 2010-07-01 |
| Completed | Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal o Urinary Calculi, Urinary Stones, Urinary Tract Stones | Phase 1 / Phase 2 | 2009-03-01 |
| Completed | Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsifica Cataract Extraction | Phase 1 / Phase 2 | 2008-05-01 |
| Completed | Double-Blind, Multicenter, Study Comparing the Efficacy and Safety of OMS103HP With Vehicle Irrigation Solutio Postoperative Pain | Phase 2 / Phase 3 | 2007-12-01 |
| Completed | Pharmacokinetic and Safety Study of OMS201 in Subjects Undergoing Ureteroscopic Treatment for Removal of Urina Urinary Calculi, Urinary Stones, Urinary Tract Stones | Phase 1 | 2007-12-01 |
| Completed | Efficacy and Safety of OMS103HP in Patients Undergoing Autograft Anterior Cruciate Ligament (ACL) Reconstructi Knee Injuries | Phase 3 | 2005-06-01 |
| Completed | Efficacy and Safety of OMS103HP in Patients Undergoing Allograft Anterior Cruciate Ligament (ACL) Reconstructi Knee Injuries | Phase 3 | 2004-11-01 |
| Completed | Safety of OMS103HP in Patients Undergoing Anterior Cruciate Ligament (ACL) Reconstruction Anterior Cruciate Ligament Reconstruction | Phase 3 | 2004-10-01 |
| Approved For Marketing | Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab Hematopoietic Stem Cell Transplant Associated Thrombotic Microangiopathy (HSCT-TMA) | — | — |